Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluocinonide for Vaginal Dryness in Breast Cancer Patients on Endocrine Therapy
NCT01422408Phase 2Completed
- Sponsor
- OHSU Knight Cancer Institute
- Start
- Sep 2011
- Primary completion
- Oct 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of fluocinonide in vaginal dryness, dyspareunia, sponsored by OHSU Knight Cancer Institute. Started Sep 2011; status: completed.
02
Drugs
fluocinonide
03
Conditions
vaginal drynessdyspareunia
Beyond the preview
Go deeper on NCT01422408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01422408.